Evotec and centogene expand collaboration into gaucher disease

Dgap-news: evotec and centogene expand collaboration into gaucher disease.centogene and evotec intend to identify novel disease-modifying targets.first target selected for development of a therapeutic candidate.centogene contributes access to its global proprietary rare disease platform, evotec will leverage its proprietary ipsc platform and drug discovery and development expertise.
CNTG Ratings Summary
CNTG Quant Ranking